# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.296576657119301	Range of duration = 2.56 to 314.53, nDeath = 25, nCensor = 20
2	AGE	ANOVA	0.0278368824525448	Range of values = 31 to 85, Mean = 57.7556, StdDev = 15.398
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.160103509181097	nTypes = 3 (DISTANT METASTASIS/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 8/9/28
4	GENDER	Fisher's exact test	0.287266703929005	nTypes = 2 (FEMALE/MALE), nPatients = 16/29
5	LYMPH.NODE.METASTASIS	Chi-square test	0.6934453203688	nTypes = 6 (N0/N1A/N1B/N2A/N2B/N3), nPatients = 27/3/4/1/2/5, nMissing = 3
6	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 45
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.838654203902323	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/3/4/6/4/3/4/2/1/1/6/6/1, nMissing = 3